InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: Headsupmonk post# 3654

Friday, 11/05/2021 11:07:27 AM

Friday, November 05, 2021 11:07:27 AM

Post# of 4271
Monk, I'm with you on this! In fact, any Big Pharma company who can afford a couple/few billion for ADMP probably already has their own compounding facilities or at least sufficient contracted capability to not need another facility. Maybe the sale of our compounding assets was a precursor to acquisition, which may have been in the works for the better part of the year. It takes a while to properly vet a multi-billion dollar deal which involves licensing deals in both directions, a new drug approval, ongoing clinical trials, etc. And it could explain the silence regarding financials, ZIMHI rollout plans, and everything else we don't know about. And as the landscape for COVID is changing almost daily - new drugs and vaxxes, new issues with drugs and vaxxes, new strains identified every week - it could be constant re-negotiation process until they can announce something.

Hopefully soon we will know just how savvy a negotiator Dr. Carlo really is!


Message in reply to:
All the more reason I think Roll is right about BO talks. Buyer will want to have their name on Tempol and prob doesn’t want the waters muddied. The stock not dropping below 1.03 kind of like a markers been placed here while something is being hashed out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMP News